Tranexamic acid for epistaxis in hereditary hemorrhagic telangiectasia patients: a European cross‐over controlled trial in a rare disease von Gaillard, S., Dupuis‐Girod, S., Boutitie, F., Rivière, S., Morinière, S., Hatron, P.‐Y., Manfredi, G., Kaminsky, P., Capitaine, A.‐L., Roy, P., Gueyffier, F., Plauchu, H.

Volltext

Publication bias in pharmacogenetics of statin-associated muscle symptoms: A meta-epidemiological study von Gougeon, A., Aribi, I., Guernouche, S., Lega, J.C., Wright, J.M., Verstuyft, C., Lajoinie, A., Gueyffier, F., Grenet, G.

Volltext

Pharmacokinetic/pharmacodynamic model of a methionine starvation based anti-cancer drug von Eymard, N., Bessonov, N., Volpert, V., Kurbatova, P., Gueyffier, F., Nony, P.

Volltext

Efficacy and safety of DPP-4 inhibitors in patients with type 2 diabetes: Meta-analysis of placebo-controlled randomized clinical trials von Rehman, M.B, Tudrej, B.V, Soustre, J, Buisson, M, Archambault, P, Pouchain, D, Vaillant-Roussel, H, Gueyffier, F, Faillie, J.-L, Perault-Pochat, M.-C, Cornu, C, Boussageon, R

Volltext

Impact of terminating reimbursement of symptomatic slow-acting drugs in osteoarthritis in France on volume and cost of drug deliveries, assessed with administrative databases von Mari, K., Rannou, F., Guillemin, F., Elegbede, M., Gueyffier, F., Badot, G., Mistretta, F.

Volltext

[OP.4A.03] PUBLIC HEALTH IMPACT OF CARDIOVASCULAR TREATMENTS IN PRIMARY PREVENTION: A SIMULATION STUDY ON A VIRTUAL REALISTIC POPULATION von Fall, M, Le, H, Marchant, I, Gueyffier, F

Volltext

Effects of pharmacological treatments on micro- and macrovascular complications of type 2 diabetes: What is the level of evidence? von Boussageon, R, Gueyffier, F, Cornu, C

Volltext

Twice- or Once-Daily Dosing of Direct Oral Anticoagulants, a systematic review and meta-analysis von Mainbourg, S., Cucherat, M., Provencher, S., Bertoletti, L., Nony, P., Gueyffier, F., Mismetti, P., Grange, C., Durieu, I., Kilo, R., Laporte, S., Grenet, G., Lega, J.-C.

Volltext

Corrigendum to “Abstracts Presented at EACPT 2017”: Clin Ther 2017;39:e66 von Gafsi, J., Gueyffier, F., Marchant, I.

Volltext

Risk Reduction or Treat-To-Target Strategy? Economic Assessment of Statin use in Cardiovascular Prevention von Gafsi, J, Gueyffier, F, Marchant, I

Volltext

Is HbA1c a valid surrogate for macrovascular and microvascular complications in type 2 diabetes? von Bejan-Angoulvant, T, Cornu, C, Archambault, P, Tudrej, B, Audier, P, Brabant, Y, Gueyffier, F, Boussageon, R

Volltext

[OP.3B.01] VALIDATION OF FRAMINGHAM AND SCORE IN 30560 PATIENTS WITH HYPERTENSION von Le, H, Marchant, I, Subtil, F, Boissel, J, Gueyffier, F

Volltext

Multivariate meta-analysis using individual participant data von Riley, R. D., Price, M. J., Jackson, D., Wardle, M., Gueyffier, F., Wang, J., Staessen, J. A., White, I. R.

Volltext

Are we using blood pressure-lowering drugs appropriately? Perhaps now is the time for a change von Gueyffier, F, Wright, J

Volltext

[OP.1A.06] DOES DIABETES REALLY HARM WOMEN MORE THAN MEN? ANALYSES FROM 30560 INDIVIDUAL PATIENT DATA von Le, H, Subtil, F, Cerou, M, Marchant, I, Lindholm, L, Thijs, L, Gueyffier, F

Volltext

How individual participant data meta-analyses have influenced trial design, conduct, and analysis von Tierney, Jayne F, Pignon, Jean-Pierre, Gueffyier, Francois, Clarke, Mike, Askie, Lisa, Vale, Claire L, Burdett, Sarah

Volltext

Efficiency of physical therapy on postural imbalance after stroke: study protocol for a systematic review and meta-analysis von Hugues, A, Di Marco, J, Janiaud, P, Xue, Y, Pires, J, Khademi, H, Cucherat, M, Bonan, I, Gueyffier, F, Rode, G

Volltext

New insights on the Pioglitazone risk-benefit ratio in European Population von Arriagada, S, Gueyffier, F, Milles, R, Marchant, I

Volltext

PP084—A European score predicts better south american cardiovascular risk than framingham risk equations von Marchant, I, Gueyffier, F

Volltext

Association between difference in blood pressure reduction and risk of cardiovascular events in a type 2 diabetes population: A meta-regression analysis von Grenet, G., Le, H.H., Bejan-Angoulvant, T., Erpeldinger, S., Boussageon, R., Kassaï, B., Moulin, P., Gueyffier, F., Cucherat, M.

Volltext